News

Altamira Therapeutics Transitions from Nasdaq to OTCQB Markets

Altamira Therapeutics Transitions from Nasdaq to OTCQB Markets

Altamira Therapeutics Transitions from Nasdaq to OTCQB

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB: CYTOF), a leader in RNA delivery technology, has announced a significant transition from being listed on The Nasdaq Stock Market to the OTCQB marketplace. This change was initiated following a determination from the Nasdaq Hearings Panel to delist the Company’s common shares due to non-compliance with their listing rules regarding maintaining a minimum bid price.

Details of the Delisting

The Nasdaq ruling came as a result of the Company’s common shares failing to reach the required minimum bid price of $1.00. Despite Altamira’s previous efforts to appeal and present a compliance strategy, the Panel denied the appeal, leading the Company to move towards trading on the OTCQB.

The planned delisting from Nasdaq is set to take place, ensuring that shareholders will continue to have access to their investments under the new trading symbol “CYTOF”. This transition is designed to facilitate uninterrupted trading activity for existing shareholders without the need for any additional measures on their part.

Focus on Growth in RNA Delivery Technology

In reflecting on this transition, Thomas Meyer, Altamira’s founder and CEO, expressed optimism about the future. He emphasized that moving to the OTCQB marketplace offers the Company a robust platform that is more suited for developing firms like Altamira, particularly given its focus on RNA delivery systems that target areas beyond just the liver.

Altamira is recognized for its innovative approach, particularly with its OligoPhore™ and SemaPhore™ platforms that promise effective RNA delivery to extrahepatic tissues. This technology serves as a backbone for their current projects including AM-401 for KRAS-driven cancer and AM-411 for rheumatoid arthritis, both of which have made significant progress in preclinical development.

Prospects and Future for Altamira Therapeutics

Shifting to the OTCQB represents a strategic opportunity for Altamira to concentrate efforts on expanding its RNA delivery platforms. As the OTCQB does not impose a minimum bid price requirement, the Company can avoid undergoing any reverse stock splits, which often pose an additional challenge for publicly traded companies.

Furthermore, Altamira continues to explore partnerships and potential licensing agreements to further enhance the reach of its advanced technology. The versatile delivery system is not limited to just siRNA but is designed to accommodate other types of RNA therapies, making it appealing for collaborations with pharmaceutical and biotech firms.

Legacy Assets and Other Initiatives

In addition to its RNA-related projects, Altamira holds a 49% stake in Altamira Medica AG, which markets Bentrio®, a nasal spray targeted at allergic rhinitis. The Company is also actively pursuing options for its inner ear legacy assets, showcasing its commitment to exploring various avenues for growth and innovation.

Conclusion

Altamira Therapeutics is poised to enter this new chapter as it transitions to the OTCQB marketplace. This move reflects the Company’s resilience and dedication to pioneering solutions in RNA delivery technology. As it continues to advance its innovative platforms and explore new opportunities, Altamira aims to solidify its position in the biotechnology landscape and deliver value to its shareholders.

Frequently Asked Questions

What prompted Altamira's transition to the OTCQB?

The transition was prompted by a decision from the Nasdaq Hearings Panel to delist the Company's shares due to non-compliance with minimum bid price regulations.

How will this affect shareholders?

Shareholders will see no interruption in trading and will continue to hold their shares under the new ticker symbol “CYTOF” on the OTCQB.

What are Altamira's primary areas of focus?

Altamira focuses on developing effective RNA delivery technologies, particularly with its OligoPhore™ and SemaPhore™ platforms, which target various applications beyond the liver.

Is Altamira planning any reverse stock splits?

No, as the OTCQB does not have a minimum bid price requirement, the Company is not planning any reverse stock splits.

What legacy assets does Altamira hold?

Altamira holds a 49% stake in Altamira Medica AG, and it is actively working on initiatives related to its nasal spray for allergic rhinitis and its inner ear assets.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 208

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 6

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 17

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 96

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
Utility Global’s India Steel Move Needs Hard Numbers

Updated Category News Views 104

Steel decarbonization announcements can sound enormous before a single bolt gets tightened. Utility Global says it plans to deploy its first industrial H2Gen project in India with Tata Steel, and that is plainly worth watching. Tata Steel is a serious industrial name, India is a consequential steel market, and any technology that can credibly lower emissions from heavy...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
LONGi's Solar-Storage Push Faces Africa's Cost Wall

Updated Category News Views 22

A vaccine refrigerator humming through a blackout is more meaningful than another climate-conference slogan. That was the useful thread running through LONGi's November 13 COP31 side event in Antalya, Türkiye: solar and storage are not merely hardware for remote communities. When designed, financed and maintained properly, they can keep clinics, water pumps and other...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 156

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 67

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading

Top 5 Most Recently Viewed Articles

Natus Medical Unveils Advanced EMG Software for Enhanced Use

Updated Category News Views 116

Natus Medical's Latest EMG Software Release Natus Medical Incorporated is excited to announce the launch of its newest edition of the Natus Elite EMG software. This software continues to set a high standard in the neurodiagnostic field, delivering both familiarity and reliability that users have come to expect. What makes this release particularly noteworthy is the...

Continue Reading
Toll Brothers Unveils New Luxury Homes in August Park Community

Updated Category News Views 231

Your Dream Home Awaits at August Park Toll Brothers, Inc., a leader in luxury home building, recently announced the launch of an exciting new community known as Toll Brothers at August Park. This neighborhood promises not just high-end living but also a tranquil environment perfect for families and individuals seeking a peaceful lifestyle. Located in a serene area, this...

Continue Reading
Johnny Bigg Expands Presence with New Concessions in Retail

Updated Category News Views 678

Johnny Bigg's Exciting Expansion into Retail Johnny Bigg, a popular fashion brand dedicated to big and tall men, continues to grow its presence in the retail landscape. Recently, the company took a significant step by launching concessions in selected Belk stores. This move marks an important milestone for Johnny Bigg, showcasing its commitment to making fashionable...

Continue Reading
Exploring Sound Investments With Warren Buffett's Wisdom

Updated Category News Views 284

Warren Buffett stood tall as the legendary investor who transformed Berkshire Hathaway into a $1 trillion powerhouse. Back then, this valuation didn’t hinge on flashy products or industry domination. It was all about Buffett’s knack for hunting down stocks that consistently outperformed the market. Berkshire Hathaway's Focused Portfolio: Goldmine or Gimmick? At one...

Continue Reading
Understanding KPIs: A Key to Effective Life Science Marketing

Updated Category News Views 205

Understanding the Importance of KPIs in Life Science Marketing In today's fast-paced life science sector, it's crucial for organizations to utilize data-driven decisions to enhance customer engagement. However, surprisingly, thirty-two percent of marketing and analytics teams in the life sciences report either not knowing about or not using key performance indicators...

Continue Reading